Determination of methocarbamol concentration in human plasma by high performance liquid chromatography-tandem mass spectrometry

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 878, Issue 9-10, 2010, Pages 831-835

  Zha, Wuyi ^a   Zhu, Zhimeng ^a  

^a Pharmascience   (Canada)

Author keywords

Bioequivalence; Human plasma; LC MS MS; Methocarbamol

Indexed keywords

BIOEQUIVALENCE STUDY; CALIBRATION CURVES; HUMAN PLASMAS; INTERNAL STANDARDS; ISOCRATIC SEPARATION; LC/MS/MS; PROTEIN PRECIPITATION; RUNTIMES; TANDEM MASS SPECTROMETRIC;

CHROMATOGRAPHIC ANALYSIS; CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH PRESSURE LIQUID CHROMATOGRAPHY; LIQUIDS; MASS SPECTROMETERS; MASS SPECTROMETRY; PLASMAS; PRECIPITATION (CHEMICAL);

PLASMA (HUMAN);

METHOCARBAMOL; TOLBUTAMIDE;

ARTICLE; BIOEQUIVALENCE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG STRUCTURE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; MAXIMUM PLASMA CONCENTRATION; NORMAL HUMAN; PRECIPITATION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY; TIME TO MAXIMUM PLASMA CONCENTRATION;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; METHOCARBAMOL; MUSCLE RELAXANTS, CENTRAL; TANDEM MASS SPECTROMETRY;

EID: 77549084788     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2010.01.025     Document Type: Article

References (11)

1. Carpenter E.B. South. Med. J. 51 (1958) 627
2. Elenbaas J.K. Am. J. Hosp. Pharm. 37 (1980) 1313
3. Muir W.W., Sams R.A., and Ashcraft S. Am. J. Vet. Res. 45 (1984) 2256
4. Bruce R.B., Turnbull L.B., and Newman J.H. J. Pharm. Sci. 60 (1971) 104
5. Campell A.D., Coles F.K., Eubank L.L., and Hut E.G. J. Pharmacol. Exp. Ther. 131 (1961) 18
6. M.J. O'Neil (senior ed.), The Merck Index, Merck Research Laboratories, Whitehouse Station, NJ, 13th ed., 2001, p. 1070.
7. Obach R., Prunonosa J., Menargues A., Nomen M., and Valles J. Biopharm. Drug Dispos. 9 (1988) 501
8. Alessi-Severini S., Coutts R.T., Jamali F., and Pasutto F.M. J. Chromatogr. 582 (1992) 173
9. Weng N.D., Lee J.W., and Hulse J.D. J. Chromatogr. B 654 (1994) 287
10. Koupai-Abyazani M.R., Esaw B., and Laviolette B. J. Anal. Toxicol. 21 (1997) 301
11. Guidance for industry, bioanalytical method validation. US Department of Health and Human Services. Food and Drug Administration, Center for Drug Evaluation and Research (CDER), May, 2001.